Frontiers in Public Health,
Год журнала:
2024,
Номер
12
Опубликована: Окт. 11, 2024
Background
Seasonal
influenza
continues
to
pose
a
substantial
public
health
challenge
for
older
adults
residing
in
rural
areas
worldwide.
Vaccination
remains
the
most
efficacious
means
of
preventing
influenza.
This
study
aimed
investigate
extent
vaccine
coverage
and
identify
factors
influencing
uptake
among
regions
south
China.
Methods
A
cross-sectional
utilizing
convenience
sampling
was
conducted
two
sites
Guangdong
Province.
Individuals
needed
meet
specific
inclusion
criteria:
(1)
attainment
60
years
age
or
older;
(2)
originating
from
households;
(3)
demonstrating
voluntary
desire
partake
survey,
either
through
written
verbal
informed
consent.
Data
encompassed
variables
such
as
socio-demographic
information,
infection
vaccination
history,
knowledge
attitudes
toward
vaccination,
perceived
beliefs
regarding
vaccine.
Univariate
multivariable
logistic
regression
analyses
were
employed
ascertain
associated
with
utilization.
In
model,
adjustments
made
gender,
age,
legal
marital
status,
highest
educational
attainment,
monthly
income.
Results
total
423
participants
ultimately
included
this
study,
majority
falling
within
range
60–75
(81.3%).
Only
one-third
had
received
an
past
year
(30.0%).
Notably,
nearly
half
exhibited
hesitancy
(45.1%).
The
analysis
revealed
that
people
robust
understanding
vaccines
positive
attitude
them
(adjusted
odds
ratio
[aOR]
=
2.60,
95%
confidence
interval
[CI]:
1.41–4.81),
along
high
level
trust
service
providers
(aOR
2.58,
CI:
1.01–6.63),
positively
receiving
year.
Conclusion
reveals
low
rate
Given
limited
adoption
significant
threat
it
poses,
there
is
urgent
imperative
devise
precise
interventions
at
enhancing
effectiveness
programs.
Tropical Medicine and Infectious Disease,
Год журнала:
2023,
Номер
8(3), С. 159 - 159
Опубликована: Март 5, 2023
As
the
COVID-19
pandemic
continues
and
transitions
to
an
endemic
stage,
booster
vaccines
will
play
important
role
in
personal
public
health.
However,
convincing
people
take
boosters
be
a
key
obstacle.
This
study
systematically
analyzed
research
that
examined
predictors
of
vaccine
hesitancy.
A
search
PubMed,
Medline,
CINAHL,
Web
Science,
Scopus
uncovered
42
eligible
studies.
Globally,
average
vaccination
hesitancy
rate
was
30.72%.
Thirteen
factors
influencing
emerged
from
literature:
demographics
(gender,
age,
education,
income,
occupation,
employment
status,
ethnicity,
marital
status),
geographical
influences
(country,
region,
residency),
adverse
events,
perceived
benefit/efficacy,
susceptibility,
severity,
prior
history
infection,
recommendations,
health
knowledge
information,
skepticism/distrust/conspiracy
theories,
type.
Vaccine
communication
campaigns
interventions
for
COVID
should
focus
on
confidence,
complacency,
convenience.
International Journal of Environmental Research and Public Health,
Год журнала:
2023,
Номер
20(3), С. 2150 - 2150
Опубликована: Янв. 25, 2023
The
Omicron
(B.1.1.529)
variant
of
the
severe
acute
respiratory
syndrome
Coronavirus
2
(SARS-CoV-2)
had
an
increased
rate
spreading
among
general
population.
Although
this
virus
mutation
resulted
in
milder
symptoms,
those
on
vulnerable
side
population
are
still
danger
developing
symptoms.
Thus,
systematic
review
focused
identifying
clinical
outcomes
older
age
patients
(>65)
that
hospitalized
with
SARS-CoV-2
variant.
research
was
conducted
using
four
electronic
databases
(PubMed,
Scopus,
Web
Science,
and
ProQuest
Central),
a
search
query
December
2022
comprised
duration
COVID-19
pandemic.
inclusion
criteria
(1)
than
65
years,
(2)
history
hospitalization
for
infection,
(3)
infection
B.1.1.529
initial
generated
295
articles,
out
which
six
were
included
review,
total
7398
patients.
main
findings
when
looking
at
elderly
population,
mortality
rates
remained
high.
This
is
because
people
more
have
comorbidities
interfere
virus’s
progress.
However,
there
inconsistency
rates,
since
data
reported
by
studies
different
selection
based
severity
infection.
no
statistically
significant
differences
found
between
unvaccinated
vaccinated
groups,
who
got
booster
doses
vaccination
lower
likelihood
serving
as
protective
factor
Human Vaccines & Immunotherapeutics,
Год журнала:
2023,
Номер
19(1)
Опубликована: Янв. 2, 2023
The
Omicron
variant
of
SARS-CoV-2
was
detected
in
October
2021
and
exhibited
high
transmissibility,
immune
evasion,
reduced
severity
when
compared
to
the
earlier
variants.
lesser
vaccine
effectiveness
against
its
created
vaccination
hesitancy
among
public.
This
review
compiled
data
reporting
relative
prevalence
as
early
variants
give
an
insight
into
existing
variants,
which
may
shape
decisions
regarding
targets
newly
developed
vaccines.
Complied
revealed
more
than
90%
within
infected
cohorts
some
countries.
BA.1
subvariant
predominated
over
BA.2
during
stages
wave.
Moreover,
BA.4/BA.5
subvariants
were
South
Africa,
USA
Italy
between
April
2022.
It
is
therefore
important
develop
vaccines
that
protect
well
are
known
cause
severe
complications.
Vaccines,
Год журнала:
2023,
Номер
11(2), С. 392 - 392
Опубликована: Фев. 8, 2023
A
second
COVID-19
vaccine
booster
dose
is
effective
and
safe
for
older
adults.
This
study
investigated
hesitancy
to
take
up
a
its
determinants
among
adults
in
Hong
Kong.
Participants
were
Chinese-speaking
community-dwelling
aged
65
years
or
above.
Telephone
numbers
randomly
selected
from
up-to-date
telephone
directories.
total
of
370
participants
completed
the
survey.
Logistic
regression
models
fitted
data
analysis.
Among
participants,
half
(52.4%)
hesitant
receive
dose.
After
adjustment
significant
background
characteristics,
perceived
benefits
(AOR:
0.50,
95%CI:
0.42,
0.60),
cues
action
0.39,
0.30,
0.52),
self-efficacy
0.37,
0.21,
0.66)
receiving
associated
with
lower
hesitancy.
Perceived
barriers
1.23,
1.12,
1.34)
fatigue
(tired
repeated
vaccination)
1.90,
1.52,
2.38)
higher
Level
was
high
Health
authorities
should
address
modify
perceptions
related
Vaccine X,
Год журнала:
2024,
Номер
18, С. 100480 - 100480
Опубликована: Март 23, 2024
The
global
deployment
of
COVID-19
vaccine
booster
dose
(VBD)
has
been
recognized
as
a
promising
therapeutic
alliance
to
provide
repeated
immunity
against
the
arrival
new
variants.
Despite
scientific
evidence
supports
effectiveness
periodic
doses,
reluctance
continues
thrive.
This
narrative
review
aimed
examine
doses
acceptance
and
summarize
an
up-to-date
assessment
potential
antecedents
associated
with
VBD
acceptance.
A
comprehensive
search
was
performed
in
several
reputable
databases
such
Medline
(via
PubMed),
Scopus,
Google
scholar,
Web
Science
from
June
10th,
2023,
August
1st,
2023.
All
relevant
descriptive
observational
studies
on
hesitancy
were
included
this
review.
total
fifty-eight
(58)
included,
Asia
representing
highest
count
thirty-one
(53
%)
studies,
Europe
eleven
(19
%),
United
States
nine
(16
other
regions
(Africa
multi-ethnic)
seven
(12
%).
Worldwide,
pooled
rate
77.09
%
(95
CI:
76.28–78.18),
willingness
(n)
=
164189,
sample
(N)
212,990.
lowest
reported
American
regions,
respectively,
85.38
85.02–85.73,
32,047,
(N
37,533)
vs.
66.92
66.56–67.4),
29335,
43,832.
However,
multi-ethnic
areas
moderately
high
79.13
78.77–79.23,
93,994,
11,8779)
72.16
71.13–72.93,
9276,
12,853),
respectively.
most
common
key
across
countries
"equal
safety",
"efficacy",
"effectiveness",
post-vaccination
"side
effects",
"community
protection"
"family
protection",
"risk-benefit
ratio",
necessity",
"trust,
"variants
control".
Disparities
uptake
observed
globally,
rates
found
Europe,
regions.
Multiple
including
safety,
efficacy,
side
effects
hesitancy.
Vaccines,
Год журнала:
2023,
Номер
11(7), С. 1177 - 1177
Опубликована: Июнь 29, 2023
The
high
prevalence
of
vaccine
booster
hesitancy,
with
the
concomitant
waning
humoral
or
hybrid
immunity,
and
emergence
SARS-CoV-2
variants
concern
can
accentuate
COVID-19
morbidity
mortality.
study
objective
was
to
ascertain
vaccination
coverage,
including
administration
precaution
(booster)
dose
vaccination,
among
older
population
in
an
urban
slum
resettlement
colony
Delhi,
India.We
conducted
a
cross-sectional
survey
colony,
slum,
village
cluster
Northeast
district
Delhi
residents
aged
≥50
years.A
total
2217
adults
(58.28%)
had
obtained
(precaution)
vaccine,
1404
(36.91%)
received
two
doses
without
dose,
121
(3.18%)
were
unvaccinated,
while
62
(1.63%)
participants
single
dose.
Based
on
adjusted
analysis,
(>65
years),
higher
education,
per-capita
income
statistically
significant
predictors
vaccination.More
than
four
ten
lacked
despite
rates
double-dose
(~95%).
Public
health
programming
should
provide
enhanced
focus
reducing
complacency
renewed
prioritization
for
improving
ease
access
services,
particularly
underserved
areas.
Cognitive Research Principles and Implications,
Год журнала:
2025,
Номер
10(1)
Опубликована: Янв. 23, 2025
Abstract
Developing
ways
to
predict
and
encourage
vaccine
booster
uptake
are
necessary
for
durable
immunity
responses.
In
a
multi-nation
sample,
recruited
in
June–August
2021,
we
assessed
delay
discounting
(one’s
tendency
choose
smaller
immediate
rewards
over
larger
future
rewards),
COVID-19
vaccination
status,
demographics,
distress
level.
Participants
who
reported
being
vaccinated
were
invited
back
one
year
later
(n
=
2547)
report
their
willingness
receive
dose,
along
with
reasons
decision.
After
controlling
demographic
variables
level,
greater
discount
was
associated
reduced
dose.
Thematic
coding
revealed
that
the
most
common
reason
protection
against
COVID-19,
unwillingness
non-necessity.
The
results
identify
as
behavioral
predictor
of
may
be
used
inform
tailored
approaches
increase
(e.g.,
trust
science
vs.
mandates).
